Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9121 to 9126 of 9126 entries
Sorted by: Best Match Show Resources per page
Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19.

Blood research

Jang HR, Lim KH.
PMID: 34801990
Blood Res. 2021 Dec 31;56(4):212-214. doi: 10.5045/br.2021.2021140.

No abstract available.

Cite
Jang HR, Lim KH. Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19. Blood Res. 2021;56(4):212-214doi: 10.5045/br.2021.2021140.
Jang, H. R., & Lim, K. H. (2021). Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19. Blood research, 56(4), 212-214. https://doi.org/10.5045/br.2021.2021140
Jang, Hee Ryeong, and Lim, Kyu-Hyoung. "Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19." Blood research vol. 56,4 (2021): 212-214. doi: https://doi.org/10.5045/br.2021.2021140
Jang HR, Lim KH. Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19. Blood Res. 2021 Dec 31;56(4):212-214. doi: 10.5045/br.2021.2021140. PMID: 34801990; PMCID: PMC8721451.
Copy Download .nbib Format: NLM
R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience.

Blood research

Lee JY, Paik JH, Suh KJ, Kim JW, Kim SH, Kim JW, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS, Lee JO.
PMID: 34801986
Blood Res. 2021 Dec 31;56(4):285-292. doi: 10.5045/br.2021.2021073.

BACKGROUND: High-dose chemotherapy followed by autologous stem cell transplantation (HDC-ASCT) as a consolidation treatment is a promising approach for eligible patients with newly diagnosed primary central nervous system lymphoma (PCNSL).METHODS: In this retrospective analysis, 22 patients with newly diagnosed...

Cite
Lee JY, Paik JH, Suh KJ, et al. R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience. Blood Res. 2021;56(4):285-292doi: 10.5045/br.2021.2021073.
Lee, J. Y., Paik, J. H., Suh, K. J., Kim, J. W., Kim, S. H., Kim, J. W., Kim, Y. J., Lee, K. W., Kim, J. H., Bang, S. M., Lee, J. S., & Lee, J. O. (2021). R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience. Blood research, 56(4), 285-292. https://doi.org/10.5045/br.2021.2021073
Lee, Ji Yun, et al. "R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience." Blood research vol. 56,4 (2021): 285-292. doi: https://doi.org/10.5045/br.2021.2021073
Lee JY, Paik JH, Suh KJ, Kim JW, Kim SH, Kim JW, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS, Lee JO. R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience. Blood Res. 2021 Dec 31;56(4):285-292. doi: 10.5045/br.2021.2021073. PMID: 34801986; PMCID: PMC8721461.
Copy Download .nbib Format: NLM
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea.

Blood research

Yi JH, Lee GW, Lee JH, Yoo KH, Jung CW, Kim DS, Lee JO, Eom HS, Byun JM, Koh Y, Yoon SS, Kim JS, Kong JH, Yhim HY, Yang DH, Yoon DH, Lim DH, Lee WS, Shin HJ.
PMID: 34801988
Blood Res. 2021 Dec 31;56(4):243-251. doi: 10.5045/br.2021.2021102.

BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia in Western countries but is rare in the East Asian countries. Due to its rarity and the lack of feasible novel agents and laboratory prognostic tools,...

Cite
Yi JH, Lee GW, Lee JH, et al. Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea. Blood Res. 2021;56(4):243-251doi: 10.5045/br.2021.2021102.
Yi, J. H., Lee, G. W., Lee, J. H., Yoo, K. H., Jung, C. W., Kim, D. S., Lee, J. O., Eom, H. S., Byun, J. M., Koh, Y., Yoon, S. S., Kim, J. S., Kong, J. H., Yhim, H. Y., Yang, D. H., Yoon, D. H., Lim, D. H., Lee, W. S., & Shin, H. J. (2021). Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea. Blood research, 56(4), 243-251. https://doi.org/10.5045/br.2021.2021102
Yi, Jun Ho, et al. "Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea." Blood research vol. 56,4 (2021): 243-251. doi: https://doi.org/10.5045/br.2021.2021102
Yi JH, Lee GW, Lee JH, Yoo KH, Jung CW, Kim DS, Lee JO, Eom HS, Byun JM, Koh Y, Yoon SS, Kim JS, Kong JH, Yhim HY, Yang DH, Yoon DH, Lim DH, Lee WS, Shin HJ. Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea. Blood Res. 2021 Dec 31;56(4):243-251. doi: 10.5045/br.2021.2021102. PMID: 34801988; PMCID: PMC8721453.
Copy Download .nbib Format: NLM
Postoperative Concurrent Chemoradiotherapy .

Frontiers in oncology

Kim TH, Cha IH, Choi EC, Kim HR, Kim HJ, Kim SH, Keum KC, Lee CG.
PMID: 33777764
Front Oncol. 2021 Mar 12;11:619372. doi: 10.3389/fonc.2021.619372. eCollection 2021.

BACKGROUND/PURPOSE: Surgery followed by postoperative radiotherapy (RT) has been considered the standard treatment for oral cavity squamous cell carcinoma (OCSCC) of advanced stages or with adverse prognostic factors. In this study, we compared the outcomes in patients with OCSCC...

Cite
Kim TH, Cha IH, Choi EC, et al. Postoperative Concurrent Chemoradiotherapy . Front Oncol. 2021;11:619372doi: 10.3389/fonc.2021.619372.
Kim, T. H., Cha, I. H., Choi, E. C., Kim, H. R., Kim, H. J., Kim, S. H., Keum, K. C., & Lee, C. G. (2021). Postoperative Concurrent Chemoradiotherapy . Frontiers in oncology, 11619372. https://doi.org/10.3389/fonc.2021.619372
Kim, Tae Hyung, et al. "Postoperative Concurrent Chemoradiotherapy ." Frontiers in oncology vol. 11 (2021): 619372. doi: https://doi.org/10.3389/fonc.2021.619372
Kim TH, Cha IH, Choi EC, Kim HR, Kim HJ, Kim SH, Keum KC, Lee CG. Postoperative Concurrent Chemoradiotherapy . Front Oncol. 2021 Mar 12;11:619372. doi: 10.3389/fonc.2021.619372. eCollection 2021. PMID: 33777764; PMCID: PMC7994509.
Copy Download .nbib Format: NLM
A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort.

Journal of chest surgery

Kim HJ, Kim JB, Kim SO, Yun SC, Lee S, Lim C, Choi JW, Hwang HY, Kim KH, Lee SH, Yoo JS, Sung K, Je HG, Hong SC, Kim YJ, Kim SH, Chang BC.
PMID: 33790059
J Chest Surg. 2021 Apr 05;54(2):88-98. doi: 10.5090/jcs.20.102.

BACKGROUND: This study aimed to develop a new risk prediction model for operative mortality in a Korean cohort undergoing heart valve surgery using the Korea Heart Valve Surgery Registry (KHVSR) database.METHODS: We analyzed data from 4,742 patients registered in...

Cite
Kim HJ, Kim JB, Kim SO, et al. A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort. J Chest Surg. 2021;54(2):88-98doi: 10.5090/jcs.20.102.
Kim, H. J., Kim, J. B., Kim, S. O., Yun, S. C., Lee, S., Lim, C., Choi, J. W., Hwang, H. Y., Kim, K. H., Lee, S. H., Yoo, J. S., Sung, K., Je, H. G., Hong, S. C., Kim, Y. J., Kim, S. H., & Chang, B. C. (2021). A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort. Journal of chest surgery, 54(2), 88-98. https://doi.org/10.5090/jcs.20.102
Kim, Ho Jin, et al. "A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort." Journal of chest surgery vol. 54,2 (2021): 88-98. doi: https://doi.org/10.5090/jcs.20.102
Kim HJ, Kim JB, Kim SO, Yun SC, Lee S, Lim C, Choi JW, Hwang HY, Kim KH, Lee SH, Yoo JS, Sung K, Je HG, Hong SC, Kim YJ, Kim SH, Chang BC. A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort. J Chest Surg. 2021 Apr 05;54(2):88-98. doi: 10.5090/jcs.20.102. PMID: 33790059; PMCID: PMC8038884.
Copy Download .nbib Format: NLM
Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea.

Clinical laboratory

Kim YJ, Jung HW, Choi YS, Chang HK, Kim SH, Yeo SG.
PMID: 35023671
Clin Lab. 2022 Jan 01;68(1). doi: 10.7754/Clin.Lab.2021.210507.

BACKGROUND: Recently, microbiome of otitis media with effusion (OME) was investigated using high throughput sequencing (HTS) in children to discover unbiased causal bacteria and natural otitis media microbiomes. However, there are very few studies in the Asian population, and...

Cite
Kim YJ, Jung HW, Choi YS, et al. Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea. Clin Lab. 2022;68(1)doi: 10.7754/Clin.Lab.2021.210507.
Kim, Y. J., Jung, H. W., Choi, Y. S., Chang, H. K., Kim, S. H., & Yeo, S. G. (2022). Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea. Clinical laboratory, 68(1), . https://doi.org/10.7754/Clin.Lab.2021.210507
Kim, Young Jin, et al. "Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea." Clinical laboratory vol. 68,1 (2022). doi: https://doi.org/10.7754/Clin.Lab.2021.210507
Kim YJ, Jung HW, Choi YS, Chang HK, Kim SH, Yeo SG. Investigation of Bacterial Community Using 16s rRNA Amplicon Sequencing for Children with Otitis Media Effusion in Korea. Clin Lab. 2022 Jan 01;68(1). doi: 10.7754/Clin.Lab.2021.210507. PMID: 35023671.
Copy Download .nbib Format: NLM
Showing 9121 to 9126 of 9126 entries